Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 2
2011 1
2012 2
2013 1
2014 1
2015 3
2016 1
2017 1
2018 2
2019 4
2020 6
2021 6
2022 10
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, Kortmann RD, Krex D, Grauer O, Goldbrunner R, Schnell O, Bähr O, Uhl M, Seidel C, Tabatabai G, Kowalski T, Ringel F, Schmidt-Graf F, Suchorska B, Brehmer S, Weyerbrock A, Renovanz M, Bullinger L, Galldiks N, Vajkoczy P, Misch M, Vatter H, Stuplich M, Schäfer N, Kebir S, Weller J, Schaub C, Stummer W, Tonn JC, Simon M, Keil VC, Nelles M, Urbach H, Coenen M, Wick W, Weller M, Fimmers R, Schmid M, Hattingen E, Pietsch T, Coch C, Glas M; Neurooncology Working Group of the German Cancer Society. Herrlinger U, et al. Among authors: misch m. Lancet. 2019 Feb 16;393(10172):678-688. doi: 10.1016/S0140-6736(18)31791-4. Epub 2019 Feb 14. Lancet. 2019. PMID: 30782343 Free article. Clinical Trial.
The genomic and transcriptional landscape of primary central nervous system lymphoma.
Radke J, Ishaque N, Koll R, Gu Z, Schumann E, Sieverling L, Uhrig S, Hübschmann D, Toprak UH, López C, Hostench XP, Borgoni S, Juraeva D, Pritsch F, Paramasivam N, Balasubramanian GP, Schlesner M, Sahay S, Weniger M, Pehl D, Radbruch H, Osterloh A, Korfel A, Misch M, Onken J, Faust K, Vajkoczy P, Moskopp D, Wang Y, Jödicke A, Trümper L, Anagnostopoulos I, Lenze D, Küppers R, Hummel M, Schmitt CA, Wiestler OD, Wolf S, Unterberg A, Eils R, Herold-Mende C, Brors B; ICGC MMML-Seq Consortium; Siebert R, Wiemann S, Heppner FL. Radke J, et al. Among authors: misch m. Nat Commun. 2022 May 10;13(1):2558. doi: 10.1038/s41467-022-30050-y. Nat Commun. 2022. PMID: 35538064 Free PMC article.
Robust methylation-based classification of brain tumours using nanopore sequencing.
Kuschel LP, Hench J, Frank S, Hench IB, Girard E, Blanluet M, Masliah-Planchon J, Misch M, Onken J, Czabanka M, Yuan D, Lukassen S, Karau P, Ishaque N, Hain EG, Heppner F, Idbaih A, Behr N, Harms C, Capper D, Euskirchen P. Kuschel LP, et al. Among authors: misch m. Neuropathol Appl Neurobiol. 2023 Feb;49(1):e12856. doi: 10.1111/nan.12856. Epub 2022 Nov 9. Neuropathol Appl Neurobiol. 2023. PMID: 36269599
A vaccine targeting mutant IDH1 in newly diagnosed glioma.
Platten M, Bunse L, Wick A, Bunse T, Le Cornet L, Harting I, Sahm F, Sanghvi K, Tan CL, Poschke I, Green E, Justesen S, Behrens GA, Breckwoldt MO, Freitag A, Rother LM, Schmitt A, Schnell O, Hense J, Misch M, Krex D, Stevanovic S, Tabatabai G, Steinbach JP, Bendszus M, von Deimling A, Schmitt M, Wick W. Platten M, et al. Among authors: misch m. Nature. 2021 Apr;592(7854):463-468. doi: 10.1038/s41586-021-03363-z. Epub 2021 Mar 24. Nature. 2021. PMID: 33762734 Free PMC article. Clinical Trial.
Clinical implementation of a 3D4K-exoscope (Orbeye) in microneurosurgery.
Rösler J, Georgiev S, Roethe AL, Chakkalakal D, Acker G, Dengler NF, Prinz V, Hecht N, Faust K, Schneider U, Bayerl S, Czabanka M, Misch M, Onken J, Vajkoczy P, Picht T. Rösler J, et al. Among authors: misch m. Neurosurg Rev. 2022 Feb;45(1):627-635. doi: 10.1007/s10143-021-01577-3. Epub 2021 Jun 18. Neurosurg Rev. 2022. PMID: 34142267 Free PMC article.
MRI-Based Risk Assessment for Incomplete Resection of Brain Metastases.
Rosenstock T, Pöser P, Wasilewski D, Bauknecht HC, Grittner U, Picht T, Misch M, Onken JS, Vajkoczy P. Rosenstock T, et al. Among authors: misch m. Front Oncol. 2022 May 16;12:873175. doi: 10.3389/fonc.2022.873175. eCollection 2022. Front Oncol. 2022. PMID: 35651793 Free PMC article.
The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns.
Glas M, Ballo MT, Bomzon Z, Urman N, Levi S, Lavy-Shahaf G, Jeyapalan S, Sio TT, DeRose PM, Misch M, Taillibert S, Ram Z, Hottinger AF, Easaw J, Kim CY, Mohan S, Stupp R. Glas M, et al. Among authors: misch m. Int J Radiat Oncol Biol Phys. 2022 Apr 1;112(5):1269-1278. doi: 10.1016/j.ijrobp.2021.12.152. Epub 2021 Dec 26. Int J Radiat Oncol Biol Phys. 2022. PMID: 34963556 Free article.
Optical Characterization of Sodium Fluorescein In Vitro and Ex Vivo.
Xu R, Teich W, Frenzel F, Hoffmann K, Radke J, Rösler J, Faust K, Blank A, Brandenburg S, Misch M, Vajkoczy P, Onken JS, Resch-Genger U. Xu R, et al. Among authors: misch m. Front Oncol. 2021 May 10;11:654300. doi: 10.3389/fonc.2021.654300. eCollection 2021. Front Oncol. 2021. PMID: 34041024 Free PMC article.
38 results